These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 1822824)

  • 1. Effects of sex steroids on serum lipids and lipoproteins.
    Jensen J
    Baillieres Clin Obstet Gynaecol; 1991 Dec; 5(4):867-87. PubMed ID: 1822824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oestrogens and atherosclerotic vascular disease--lipid factors.
    Newnham HH
    Baillieres Clin Endocrinol Metab; 1993 Jan; 7(1):61-93. PubMed ID: 8435058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of post-menopausal oestrogen-progestogen replacement therapy on serum lipids and lipoproteins: a review.
    Rijpkema AH; van der Sanden AA; Ruijs AH
    Maturitas; 1990 Sep; 12(3):259-85. PubMed ID: 2145495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low-dose progesterone therapy in oestrogenised postmenopausal women: effects on plasma lipids, lipoproteins and liver function parameters.
    Bolaji II; Grimes H; Mortimer G; Tallon DF; Fottrell PF; O'Dwyer EM
    Eur J Obstet Gynecol Reprod Biol; 1993 Jan; 48(1):61-8. PubMed ID: 8449263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of estradiol on blood lipids and lipoproteins in postmenopausal women.
    Fåhraeus L
    Obstet Gynecol; 1988 Nov; 72(5 Suppl):18S-22S. PubMed ID: 3173937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hormonal contraception and substitution therapy: the importance of progestogen for cardiovascular diseases].
    Kuhl H
    Geburtshilfe Frauenheilkd; 1992 Nov; 52(11):653-62. PubMed ID: 1452000
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum lipids, lipoproteins, and apolipoproteins during postmenopausal estrogen replacement therapy combined with either 19-nortestosterone derivatives or 17-hydroxyprogesterone derivatives.
    Haarbo J; Hassager C; Jensen SB; Riis BJ; Christiansen C
    Am J Med; 1991 May; 90(5):584-9. PubMed ID: 1827568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Postmenopause, plasma lipoproteins, and hormone replacement therapy].
    Insúa A; Massari F; Zanchetta JR
    Medicina (B Aires); 1993; 53(4):364-70. PubMed ID: 8201920
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The influence of transdermal oestradiol replacement therapy and medroxyprogesterone acetate on serum lipids and lipoproteins.
    Bhathena RK; Anklesaria BS; Ganatra AM; Pinto R
    Br J Clin Pharmacol; 1998 Feb; 45(2):170-2. PubMed ID: 9491833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of hormone replacement therapy on the levels of serum lipids, apolipoprotein AI, apolipoprotein B and lipoprotein (a) in Turkish postmenopausal women.
    Bayrak A; Aldemir DA; Bayrak T; Corakçi A; Dursun P
    Arch Gynecol Obstet; 2006 Aug; 274(5):289-96. PubMed ID: 16810536
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipids and cardiovascular disease: do the findings and therapy apply equally to men and women?
    LaRosa JC
    Womens Health Issues; 1992; 2(2):102-11; discussion 111-3. PubMed ID: 1617306
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of postmenopausal hormone substitution on the lipid profile and coagulation factors in female smokers].
    Tatović-Babić D; Beljić T; Drezgić M; Trpković D; Balint-Perić L; Babić D; Nikolić J
    Srp Arh Celok Lek; 2002; 130(11-12):371-5. PubMed ID: 12751159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative cardiovascular effects of different progestins in menopause.
    Rosano GM; Fini M
    Int J Fertil Womens Med; 2001; 46(5):248-56. PubMed ID: 11720197
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence for primary and secondary prevention of coronary artery disease in women taking oestrogen replacement therapy.
    Bush TL
    Eur Heart J; 1996 Aug; 17 Suppl D():9-14. PubMed ID: 8869876
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect on plasma lipids and lipoproteins of postmenopausal oestrogen therapy with added dydrogesterone.
    Siddle NC; Jesinger DK; Whitehead MI; Turner P; Lewis B; Prescott P
    Br J Obstet Gynaecol; 1990 Dec; 97(12):1093-100. PubMed ID: 2177647
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The menopause: benefits and risks of estrogen-progestogen replacement therapy.
    Gambrell RD
    Fertil Steril; 1982 Apr; 37(4):457-74. PubMed ID: 7040116
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation by progestogens of the effects of oestrogen on hepatic endocrine function in postmenopausal women.
    Nugent AG; Leung KC; Sullivan D; Reutens AT; Ho KK
    Clin Endocrinol (Oxf); 2003 Dec; 59(6):690-8. PubMed ID: 14974909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of different progestogens on lipoproteins during postmenopausal replacement therapy.
    Hirvonen E; Mälkönen M; Manninen V
    N Engl J Med; 1981 Mar; 304(10):560-3. PubMed ID: 7453723
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A 2-year study on the beneficial effects of 17 beta-oestradiol-dydrogesterone therapy on serum lipoproteins and Lp(a) in postmenopausal women: no additional unfavourable effects of dydrogesterone.
    van der Mooren MJ; Demacker PN; Thomas CM; Borm GF; Rolland R
    Eur J Obstet Gynecol Reprod Biol; 1993 Dec; 52(2):117-23. PubMed ID: 8157140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of estrogen replacement therapy on lipids. Implications for cardiovascular risk.
    LaRosa JC
    J Reprod Med; 1985 Oct; 30(10 Suppl):811-3. PubMed ID: 4078813
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.